NCT05626218

Brief Summary

This research was planned as a randomized controlled experimental study to reduce the anxiety expectant mothers feel when on a non-stress test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 23, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2023

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

3 months

First QC Date

November 15, 2022

Last Update Submit

June 20, 2023

Conditions

Keywords

anxietypregnancystress ballnon-stress test

Outcome Measures

Primary Outcomes (2)

  • Introductory Information form

    A form that includes questions about women's socio-demographic and pregnancy and characteristics. A form that includes questions about women's socio-demographic and pregnancy and characteristics.

    between one to six months

  • the Spielberger State-Trait Anxiety Inventory (STAI/1-2) scale

    This scale, developed by Spielberg in 1973, consists of 40 questions. It is a 4-point Likert type scale (1=not at all, 4=very much). The lowest score that can be obtained from the scale is 20, and the highest score is 80. The higher the score is, the higher the anxiety level is. The alpha value of the scale is 0.86-.92.33. The validity and reliability study in our country was conducted by Oner et al., in 1983 and the alpha value was found between. The scale that will be used to evaluate the state and trait anxiety of pregnant women. As the score increases, it is determined that the anxiety is higher.

    between one to six months

Study Arms (2)

Stress ball group

EXPERIMENTAL

A stress ball will be applied to pregnant women with anxiety during NST.

Other: stress ball

Control group

NO INTERVENTION

Participants in this group will consist of people who do not routinely do any practice on their own to reduce anxiety symptoms.

Interventions

The woman is usually laid in the last side position during the procedure. A stress ball will be given to the right hand of the participants during the NST procedure (average 15-20 minutes). This stress ball will be squeezed for 2-3 seconds, and then the hand and arm will be told to relax. This process will be repeated throughout the NST. Hospital protocol will also be applied to these participants.

Stress ball group

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Ability to read and understand Turkish
  • Being between the ages of 20-35
  • Single pregnancy
  • Having had NST before
  • ¬- Have eaten at least 2 hours before the NST procedure
  • Don't be primiparous
  • Getting 37 or less on the trait anxiety (STAI-1) scale
  • Getting 37 or more on the state anxiety (STAI-2) scale
  • Volunteering to participate in the research
  • Fully answering survey and scale forms
  • Being in the 3rd trimester

You may not qualify if:

  • Having been diagnosed with a risky pregnancy
  • Unwilling to continue working
  • Having a chronic disease (Diabetes, Hypertension, Thyroid etc.),
  • Having any problem that prevents communication (such as hearing, speaking, and understanding abilities),
  • Using one of the pharmacological or non-pharmacological methods to reduce stress and receiving psychiatric treatment (Pharmacotherapy or psychotherapy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova University

Adana, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Elif Dağlı, Phd

    Cukurova University

    PRINCIPAL INVESTIGATOR
  • AYCA SOLT KIRCA, Phd

    Kırklareli University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asssistant professor

Study Record Dates

First Submitted

November 15, 2022

First Posted

November 23, 2022

Study Start

February 1, 2023

Primary Completion

May 15, 2023

Study Completion

June 20, 2023

Last Updated

June 22, 2023

Record last verified: 2023-06

Locations